Perceptive Advisors »

Biodesix shares owned by Perceptive Advisors

Quarter-by-quarter ownership of Biodesix shares owned by Perceptive Advisors from 13F filings

Historical chart of Perceptive Advisors investment in Biodesix

Tip: Access up to 7 years of quarterly data

All positions including Biodesix held by Perceptive Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biodesix by Perceptive Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $821k 109k 7.55

More positions owned by Perceptive Advisors

Rhythm Pharmaceuticals (RYTM)
Ascendis Pharma A/s Sponsored Adr (ASND)
Arcellx Common Stock (ACLX)
Celcuity (CELC)
Nuvalent Inc-a (NUVL)
Merus N V (MRUS)
Amylyx Pharmaceuticals (AMLX)
Roivant Sciences SHS (ROIV)
Meiragtx Holdings (MGTX)
Insmed Com Par $.01 (INSM)
Travere Therapeutics (TVTX)
CryoLife (AORT)
Praxis Precision Medicines I Com New (PRAX)
Immatics SHS (IMTX)
Centessa Pharmaceuticals Sponsored Ads (CNTA)

View all positions for Perceptive Advisors

Top funds holding Biodesix

Telemark Asset Management
Standard Life Aberdeen
Vanguard Group
Perceptive Advisors
Monashee Investment Management
Perkins Capital Management
Silverarc Capital Management
GSA Capital Partners
Balyasny Asset Management
Geode Capital Management
BlackRock
Susquehanna International
State Street Corporation
Oracle Investment Management
Millennium Management

View all funds holding Biodesix